With due regard for ultimate deal mathematics, Reckitt Benckiser’s (RB/ LN, BUY, T/P 9000p) announcement that it is in talks with American consumer health company Mead Johnson should be lauded. Reckitt has long stated that consumer health is a priority and it has been clear for some time that the company has more than adequate finances to execute a transformational deal in the sub-segment.
02 Feb 2017
Delivering on message
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Delivering on message
Reckitt Benckiser Group plc (RKT:LON) | 4,140 1200.6 0.7% | Mkt Cap: 29,259m
- Published:
02 Feb 2017 -
Author:
Chris Wickham -
Pages:
4
With due regard for ultimate deal mathematics, Reckitt Benckiser’s (RB/ LN, BUY, T/P 9000p) announcement that it is in talks with American consumer health company Mead Johnson should be lauded. Reckitt has long stated that consumer health is a priority and it has been clear for some time that the company has more than adequate finances to execute a transformational deal in the sub-segment.